Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.

MLA

Otani, Toshihito, et al. “Risk Factors Associated with Increased Discontinuation Rate of Trimethoprim-Sulfamethoxazole Used as a Primary Prophylaxis for Pneumocystis Pneumonia: A Retrospective Cohort Study.” Pulmonary Pharmacology & Therapeutics, vol. 67, Apr. 2021, p. 101999. EBSCOhost, https://doi.org/10.1016/j.pupt.2021.101999.

APA

Otani, T., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Iwamoto, H., Hirata, S., Fujitaka, K., Hamada, H., Sugiyama, E., & Hattori, N. (2021). Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study. Pulmonary Pharmacology & Therapeutics, 67, 101999. https://doi.org/10.1016/j.pupt.2021.101999

Chicago

Otani, Toshihito, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, et al. 2021. “Risk Factors Associated with Increased Discontinuation Rate of Trimethoprim-Sulfamethoxazole Used as a Primary Prophylaxis for Pneumocystis Pneumonia: A Retrospective Cohort Study.” Pulmonary Pharmacology & Therapeutics 67 (April): 101999. doi:10.1016/j.pupt.2021.101999.